Category: Oncology/Hematology
Oncology/Hematology market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Cancer Registry Software
The 2025-2030 World Outlook for Cancer Registry Software This study covers the world outlook for cancer registry software across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Cancer Screenings
The 2025-2030 World Outlook for Cancer Screenings This study covers the world outlook for cancer screenings across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Cancer Specialty Hospitals
The 2025-2030 World Outlook for Cancer Specialty Hospitals This study covers the world outlook for cancer specialty hospitals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Cancer Supportive Care Drugs
The 2025-2030 World Outlook for Cancer Supportive Care Drugs This study covers the world outlook for cancer supportive care drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Cancer Therapeutics
The 2025-2030 World Outlook for Cancer Therapeutics This study covers the world outlook for cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Pancreatic Cancer Drugs
The 2025-2030 World Outlook for Pancreatic Cancer Drugs This study covers the world outlook for pancreatic cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Pap Smear Tests for Cervical Cancer Diagnostic Testing
The 2025-2030 World Outlook for Pap Smear Tests for Cervical Cancer Diagnostic Testing This study covers the world outlook for pap smear tests for cervical cancer diagnostic testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indust ... Read More
-
The 2025-2030 World Outlook for Cancer Stem Cells
The 2025-2030 World Outlook for Cancer Stem Cells This study covers the world outlook for cancer stem cells across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Cancer Supportive Care
The 2025-2030 World Outlook for Cancer Supportive Care This study covers the world outlook for cancer supportive care across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Cancer Testing-Screening
The 2025-2030 World Outlook for Cancer Testing-Screening This study covers the world outlook for cancer testing-screening across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Cancer Diagnostics
The 2025-2030 World Outlook for Cancer Diagnostics This study covers the world outlook for cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Urothelial Cancer Drugs
The 2025-2030 World Outlook for Urothelial Cancer Drugs This study covers the world outlook for urothelial cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Interventional Oncology
The 2025-2030 World Outlook for Interventional Oncology This study covers the world outlook for interventional oncology across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Ovarian Cancer Diagnostics
The 2025-2030 World Outlook for Ovarian Cancer Diagnostics This study covers the world outlook for ovarian cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Ovarian Cancer Drugs
The 2025-2030 World Outlook for Ovarian Cancer Drugs This study covers the world outlook for ovarian cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Head and Neck Cancers
The 2025-2030 World Outlook for Head and Neck Cancers This study covers the world outlook for head and neck cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Imaging Devices
The 2025-2030 World Outlook for Breast Cancer Imaging Devices This study covers the world outlook for breast cancer imaging devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Cancer Diagnostics Laboratory Tests
The 2025-2030 World Outlook for Cancer Diagnostics Laboratory Tests This study covers the world outlook for cancer diagnostics laboratory tests across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Cancer Immunotherapies
The 2025-2030 World Outlook for Cancer Immunotherapies This study covers the world outlook for cancer immunotherapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Cancer Immunotherapy Monoclonal Antibodies
The 2025-2030 World Outlook for Cancer Immunotherapy Monoclonal Antibodies This study covers the world outlook for cancer immunotherapy monoclonal antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More
-
The 2025-2030 World Outlook for Hemato Oncology Testing
The 2025-2030 World Outlook for Hemato Oncology Testing This study covers the world outlook for hemato oncology testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Hematology and Oncology Products
The 2025-2030 World Outlook for Hematology and Oncology Products This study covers the world outlook for hematology and oncology products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Anaplastic Thyroid Cancer Drugs
The 2025-2030 World Outlook for Anaplastic Thyroid Cancer Drugs This study covers the world outlook for anaplastic thyroid cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Endocrine Pancreatic Cancer Drugs
The 2025-2030 World Outlook for Endocrine Pancreatic Cancer Drugs This study covers the world outlook for endocrine pancreatic cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Endometrial Cancer Treatments
The 2025-2030 World Outlook for Endometrial Cancer Treatments This study covers the world outlook for endometrial cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
Research Assistance
